Upcoming Webinars

 

Check back for more information about upcoming webinars.

 

Past Webinars

 

Click on the titles for a full description and to watch the recorded webinar.

May 20012: Inequities in Breast Cancer: Race and Place Matter

March 2012: Protecting Our Health and Environment: Uniting to Change U.S. Chemical Policy
 
Feb 2012: Turning Knowledge Into Action: The Think Before You Pink® Toolkit
 
Jan 2012: New Report on Breast Cancer and the Environment: A Briefing for Advocates
 
November 2011: Toxic Cosmetics: What’s in Your Personal Care Products and What You Can Do About It
 
October 2011: Make Action Speak Louder Than Pink
 
August 2011: Gene Patenting
 
July 2011: Sorting Out the Confusion: An In-Depth Look at Breast Cancer Screening
 
June 2011: Big Pharma, the FDA and Breast Cancer: Patients Before Profit
 
May 2011: The Politics of Breast Cancer

__________________________________________________________________

Inequities in Breast Cancer: Race and Place Matter (May 2012)

Inequities in breast cancer risk and outcomes vary among different racial and ethnic communities and are well documented. In our efforts to address and end this disease, health activists, practitioners, and legislators must focus on the social and economic context in which the disease arises. As a society, we can affect and potentially avoid these unjust inequities in breast cancer.

On this webinar, you will learn about:

• How where we live, work and play defines our access to good health
• Breast cancer inequities in underserved communities
• How you can work for health equity

 

 

Protecting Our Health and Environment: Uniting to Change U.S. Chemical Policy (March 2012)

On this webinar you will learn how legislative chemical reform affects you, your family and your community, and how to advocate for change that will protect all of our health.

There are more than 80,000 chemicals on the market which have never been fully assessed for toxic impacts on human health and the environment. Environmental toxins in our everyday lives can increase our risk of breast cancer, and our current regulatory system has little power to protect us.

Presented by Sahru Keiser, Breast Cancer Action’s Program Associate of Education and Mobilization, Andy Igrejas, National Campaign Director for the Safer Chemicals, Healthy Families Coalition and Sharyle Patton, Director of Commonweal’s Biomonitoring Resource Center. On the webinar you will learn about: 

•   Current chemical policy in the U.S. and the need for reform
•   Chemicals and  the connection to breast cancer
•   The nuts and bolts of the Safe Chemicals Act of 2011
•   How Breast Cancer Action is working to end the breast cancer epidemic
•   Ways for you to take action

Breast Cancer Action is part of the national Safer Chemicals, Healthy Families Coalition, which advocates for federal policy that helps stop breast cancer before it starts through stronger regulation of toxins linked to breast cancer.

 

 

Turning Knowledge Into Action: The Think Before You Pink® Toolkit (Feb 2012)

This webinar will walk you through the tools and resources of Breast Cancer Action’s brand new Think Before You Pink® Toolkit, which puts the power of change in your hands. Learn about the multiple resources, action items, and tools contained within the toolkit. The webinar features Breast Cancer Action’s Sahru Keiser, MPH Program Associate of Education and  Mobilization, Kim Irish, J.D. Program Manager and Breast Cancer Action member, Robyn Stoetzel R.N., B.S.N. On the webinar you will learn about:

• The tools and information provided in the toolkit as well as how to use them

• The critical questions you can ask before you or your friends buy pink ribbon products
• How you can influence companies in their decisions for October pink marketing campaigns 
• How others are using the toolkit to change the conversation about the breast cancer epidemic

 

 

New Report on Breast Cancer and the Environment: A Briefing for Advocates (Jan 2012)

Breast Cancer Action’s executive director, Karuna Jaggar presented joined by Janet Ackerman, Research Assistant at the Silent Spring Institute on Jan 24th and joined by Ruthann Rudel, MS, Director of Research at the Silent Spring Institute on Jan 25th.

The webinar provided:

• BCAction’s commentary and analysis of the IOM report on breast cancer and the environment
• A summary of where the report got it right and where it missed the mark
• A focus on the limits of individual behavior and the policy changes required to reduce these exposures to toxins that may be contributing to the skyrocketing rates of breast and other cancers
• Review the committee’s recommendations and discuss how advocates can move these recommendations forward

 

Toxic Cosmetics: What’s in Your Personal Care Products and What You Can Do About It (November 2011)

Co-hosted by Nneka Leiba, Senior Analyst with the Environmental Working Group and Mia Davis, Organizing Director with the Campaign for Safe Cosmetics. Through this webinar you’ll learn:

• A brief summary of the problem with cosmetic regulation
• Who is at risk when it comes to toxins in personal care products
• Why we need safer cosmetics
• What chemicals we’re talking about when we say “toxic cosmetics”
• Current and past legislation aimed at regulating cosmetics
• Ways for you to take action to protect everyone’s health There will be time for questions, so bring your questions!

 

Make Action Speak Louder Than Pink (October 2011)

Co-hosted by author of Pink Ribbon Blues Gayle Sulik. This webinar covers:

• Why the pink ribbon appears on so many products, especially in October
• The history of Breast Cancer Awareness Month and its corporate ties
• How BCAction’s Think Before You Pink campaign has challenged pinkwashers for 10 years
• Ways you can take action in BCAction’s Raise a Stink! campaign

 

Gene Patenting (August 2011)

This webinar addresses gene patenting and its implications for women around the world. Participants learn about the latest news in the Myriad Genetics case, along with the basic science, patent law, and current campaign efforts. Breast Cancer Action is a plaintiff in the lawsuit to invalidate Myriad Genetics’ patents on the breast cancer genes BRCA 1 and 2 because patients should always come before profits.

Sorting Out the Confusion: An In-Depth Look at Breast Cancer Screening (July 2011)

When the U.S. Preventive Services Task Force (USPSTF) announced new recommendations for mammography screening in 2009, the ensuing media frenzy generated a lot of heated conversation. In the midst of that debate, BCAction was one of the few breast cancer organizations to acknowledge mammography’s limitations and call for safer, more effective screening methods. This webinar delineates the risks and benefits of breast cancer screening, review the science behind the USPSTF’s recommendations, and provide attendees with tools for understanding media coverage of mammography. Join us for an illuminating look at a complex and often confusing issue.

Featuring: Tracy Weitz, BCAction Board Chair and Director, Advancing New Standards in Reproductive Health (ANSIRH), University of California, San Francisco

 

Big Pharma, the FDA and Breast Cancer: Patients Before Profit (June 2011)

Following The Politics of Breast Cancer webinar in May, we turned BCAction’s critical eye on the FDA and its drug approval process.

Breast cancer treatments should be both the most effective and the least toxic possible. The standards used by the FDA for the approval of new breast cancer therapies and devices should ensure this outcome. However, pharmaceutical companies, the government and cancer patients don’t share the same interests.  This webinar will talk about whom the power players at the FDA are, BCAction’s take on the related conflicts of interests, and the history of the approval process.

 

The Politics of Breast Cancer (May 2011)

Why does BCAction so fiercely object to Breast Cancer Awareness Month? What is so wrong with pink ribbon marketing? Why on earth would corporations involved in the treatment and diagnosis of women with breast cancer try to control how the public understands the disease?

Here’s a crash course on the “pinking” of breast cancer, environmental causes of the disease and the corporate interests that control what the public hears about the epidemic.